Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 2
1988 4
1989 9
1990 6
1993 4
1994 10
1995 5
1996 6
1997 13
1998 6
1999 6
2000 5
2001 8
2002 6
2003 6
2004 19
2005 16
2006 22
2007 14
2008 18
2009 40
2010 41
2011 53
2012 65
2013 48
2014 43
2015 33
2016 26
2017 24
2018 34
2019 50
2020 40
2021 41
2022 48
2023 29
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

700 results

Results by year

Filters applied: . Clear all
Page 1
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N. Umemura S, et al. Among authors: rakugi h. Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9. Hypertens Res. 2019. PMID: 31375757 Review. No abstract available.
Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study.
Kario K, Rakugi H, Yarimizu D, Morita Y, Eguchi S, Iekushi K. Kario K, et al. Among authors: rakugi h. J Am Heart Assoc. 2023 Apr 18;12(8):e027612. doi: 10.1161/JAHA.122.027612. Epub 2023 Apr 7. J Am Heart Assoc. 2023. PMID: 37026551 Free PMC article. Clinical Trial.
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Kimura N, et al. Among authors: rakugi h. Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24521857
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Naruse M, et al. Among authors: rakugi h. Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12. Endocr J. 2022. PMID: 35418526 Free article.
Prologue: Special Spotlight Issue on Japan.
Yano Y, Nishiyama A, Ishimitsu T, Kashihara N, Rakugi H, Tamura K, Itoh H, Tsuchihashi T, Sakima A, Arima H, Matayoshi T, Imai Y, Miura K, Hisamatsu T, Asayama K, Ohkubo T, Node K, Kario K. Yano Y, et al. Among authors: rakugi h. J Hum Hypertens. 2021 Aug 2. doi: 10.1038/s41371-021-00589-2. Online ahead of print. J Hum Hypertens. 2021. PMID: 34341468 No abstract available.
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.
Ouchi Y, Sasaki J, Arai H, Yokote K, Harada K, Katayama Y, Urabe T, Uchida Y, Hayashi M, Yokota N, Nishida H, Otonari T, Arai T, Sakuma I, Sakabe K, Yamamoto M, Kobayashi T, Oikawa S, Yamashita S, Rakugi H, Imai T, Tanaka S, Ohashi Y, Kuwabara M, Ito H. Ouchi Y, et al. Among authors: rakugi h. Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434507 Clinical Trial.
Step for breaking free from clinical inertia.
Rakugi H. Rakugi H. Hypertens Res. 2022 Jan;45(1):5-7. doi: 10.1038/s41440-021-00767-2. Epub 2021 Oct 17. Hypertens Res. 2022. PMID: 34657132 No abstract available.
700 results